 Vijayalakshmi Karoor
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neprilysin | 4 | 2017 | 48 | 1.400 |
Why?
| | rho GTP-Binding Proteins | 2 | 2020 | 65 | 1.310 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2017 | 454 | 1.150 |
Why?
| | Hypoxia | 8 | 2023 | 963 | 1.070 |
Why?
| | Hypertension, Pulmonary | 11 | 2021 | 1794 | 0.960 |
Why?
| | Pulmonary Artery | 13 | 2020 | 1063 | 0.950 |
Why?
| | Vascular Remodeling | 3 | 2021 | 152 | 0.920 |
Why?
| | rhoA GTP-Binding Protein | 4 | 2019 | 80 | 0.910 |
Why?
| | rho-Associated Kinases | 5 | 2019 | 84 | 0.900 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 2 | 2012 | 86 | 0.790 |
Why?
| | Butyrates | 1 | 2021 | 54 | 0.780 |
Why?
| | Metabolic Diseases | 1 | 2021 | 103 | 0.750 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 200 | 0.720 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 236 | 0.700 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 79 | 0.680 |
Why?
| | Metabolome | 1 | 2021 | 296 | 0.660 |
Why?
| | Pneumonia | 2 | 2021 | 592 | 0.600 |
Why?
| | Vascular Diseases | 1 | 2019 | 241 | 0.560 |
Why?
| | Endothelial Cells | 6 | 2023 | 732 | 0.560 |
Why?
| | Myocardium | 3 | 2019 | 970 | 0.550 |
Why?
| | Muscle Proteins | 1 | 2017 | 219 | 0.550 |
Why?
| | Quinazolines | 3 | 2012 | 245 | 0.510 |
Why?
| | Vasa Vasorum | 3 | 2020 | 32 | 0.510 |
Why?
| | Carcinogens | 2 | 2012 | 108 | 0.500 |
Why?
| | Lung | 6 | 2021 | 3664 | 0.490 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 25 | 0.450 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 907 | 0.450 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1798 | 0.440 |
Why?
| | Piperidines | 2 | 2012 | 171 | 0.430 |
Why?
| | Animals | 30 | 2023 | 33381 | 0.430 |
Why?
| | Neovascularization, Pathologic | 4 | 2020 | 287 | 0.380 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 384 | 0.360 |
Why?
| | Lung Neoplasms | 3 | 2012 | 2220 | 0.360 |
Why?
| | Aging | 1 | 2020 | 1670 | 0.350 |
Why?
| | ErbB Receptors | 2 | 2012 | 569 | 0.350 |
Why?
| | Signal Transduction | 9 | 2020 | 4709 | 0.330 |
Why?
| | Hemoglobins | 3 | 2021 | 326 | 0.320 |
Why?
| | Anemia, Sickle Cell | 2 | 2021 | 230 | 0.300 |
Why?
| | Heart Failure | 1 | 2019 | 1969 | 0.280 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2020 | 115 | 0.270 |
Why?
| | Mice, Knockout | 6 | 2023 | 2680 | 0.270 |
Why?
| | Propranolol | 1 | 2004 | 54 | 0.240 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 7 | 0.240 |
Why?
| | Enzyme Activation | 5 | 2017 | 828 | 0.230 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2020 | 140 | 0.230 |
Why?
| | Macrophages | 2 | 2021 | 1324 | 0.230 |
Why?
| | Rats | 10 | 2021 | 5392 | 0.230 |
Why?
| | Up-Regulation | 2 | 2021 | 872 | 0.220 |
Why?
| | Mice | 12 | 2023 | 15520 | 0.210 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2021 | 146 | 0.210 |
Why?
| | Endothelin-1 | 2 | 2017 | 168 | 0.210 |
Why?
| | Sleep Apnea Syndromes | 2 | 2013 | 80 | 0.210 |
Why?
| | Hemopexin | 1 | 2021 | 13 | 0.210 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2004 | 301 | 0.200 |
Why?
| | Urethane | 2 | 2012 | 41 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 5 | 2021 | 2478 | 0.200 |
Why?
| | Systole | 1 | 2021 | 168 | 0.200 |
Why?
| | Tight Junctions | 1 | 2021 | 69 | 0.200 |
Why?
| | Acetylation | 1 | 2021 | 217 | 0.190 |
Why?
| | Microvessels | 1 | 2021 | 77 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2023 | 359 | 0.190 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2020 | 155 | 0.190 |
Why?
| | Cytokines | 3 | 2021 | 1900 | 0.190 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 14 | 0.190 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 16 | 0.180 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 58 | 0.180 |
Why?
| | Endothelium | 1 | 2020 | 120 | 0.180 |
Why?
| | Blood Pressure | 4 | 2021 | 1664 | 0.180 |
Why?
| | Ligands | 1 | 2021 | 567 | 0.180 |
Why?
| | Cell Proliferation | 3 | 2017 | 2275 | 0.180 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 4908 | 0.170 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 71 | 0.170 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 59 | 0.170 |
Why?
| | Cell Movement | 2 | 2017 | 896 | 0.160 |
Why?
| | Adenosine | 1 | 2020 | 211 | 0.160 |
Why?
| | Pulmonary Circulation | 3 | 2009 | 424 | 0.160 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 14 | 0.160 |
Why?
| | Immune System | 1 | 2019 | 181 | 0.160 |
Why?
| | Leukocytes | 1 | 2019 | 290 | 0.160 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 9 | 0.160 |
Why?
| | Xanthine Dehydrogenase | 1 | 2017 | 34 | 0.150 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 56 | 0.150 |
Why?
| | Dehydroepiandrosterone | 2 | 2008 | 50 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2019 | 331 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 394 | 0.150 |
Why?
| | Phenotype | 2 | 2017 | 3003 | 0.150 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.150 |
Why?
| | Microfilament Proteins | 1 | 2017 | 134 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2018 | 85 | 0.140 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 81 | 0.140 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 576 | 0.140 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 217 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2021 | 727 | 0.140 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 156 | 0.140 |
Why?
| | Humans | 13 | 2021 | 118972 | 0.130 |
Why?
| | Nicotine | 1 | 2018 | 276 | 0.130 |
Why?
| | Inflammation | 2 | 2023 | 2566 | 0.130 |
Why?
| | Actins | 1 | 2017 | 404 | 0.130 |
Why?
| | Glycolysis | 1 | 2016 | 224 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2017 | 4077 | 0.130 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 181 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 472 | 0.130 |
Why?
| | Fibroblasts | 1 | 2019 | 842 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 969 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 811 | 0.120 |
Why?
| | Models, Biological | 1 | 2021 | 1715 | 0.120 |
Why?
| | Genotype | 2 | 2017 | 1882 | 0.120 |
Why?
| | Blotting, Western | 3 | 2012 | 1194 | 0.120 |
Why?
| | Methylcholanthrene | 1 | 2012 | 18 | 0.110 |
Why?
| | Butylated Hydroxytoluene | 1 | 2012 | 32 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 195 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 298 | 0.100 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2002 | 107 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2025 | 0.100 |
Why?
| | Alcoholism | 1 | 2017 | 717 | 0.100 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 176 | 0.090 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 219 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2007 | 1094 | 0.090 |
Why?
| | Chemoprevention | 1 | 2010 | 89 | 0.090 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2010 | 59 | 0.090 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 111 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3588 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1137 | 0.080 |
Why?
| | Monocrotaline | 1 | 2008 | 35 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 1945 | 0.080 |
Why?
| | Antioxidants | 1 | 2012 | 564 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3730 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2010 | 356 | 0.080 |
Why?
| | Guanylate Cyclase | 1 | 2007 | 36 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 207 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2005 | 404 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1059 | 0.070 |
Why?
| | Calcineurin | 2 | 2003 | 95 | 0.070 |
Why?
| | Serotonin | 1 | 2007 | 309 | 0.070 |
Why?
| | Cattle | 2 | 2020 | 978 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 195 | 0.070 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2004 | 8 | 0.060 |
Why?
| | Arrestins | 1 | 2004 | 15 | 0.060 |
Why?
| | Heat Shock Transcription Factors | 1 | 2023 | 17 | 0.060 |
Why?
| | Angiotensin II | 1 | 2004 | 107 | 0.060 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2003 | 4 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1284 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2010 | 812 | 0.060 |
Why?
| | Male | 12 | 2020 | 57801 | 0.060 |
Why?
| | Heat-Shock Response | 1 | 2023 | 59 | 0.060 |
Why?
| | Autonomic Nervous System | 1 | 2003 | 66 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 285 | 0.060 |
Why?
| | Phosphorylation | 2 | 2004 | 1633 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2023 | 182 | 0.050 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2002 | 14 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2023 | 193 | 0.050 |
Why?
| | Oxidative Stress | 2 | 2020 | 1178 | 0.050 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 1974 | 0.050 |
Why?
| | Myocardial Contraction | 1 | 2003 | 339 | 0.050 |
Why?
| | Enzyme Inhibitors | 2 | 2005 | 827 | 0.050 |
Why?
| | Protein Kinases | 1 | 2004 | 310 | 0.050 |
Why?
| | Heme | 1 | 2021 | 54 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2001 | 61 | 0.050 |
Why?
| | Cyclosporine | 1 | 2001 | 173 | 0.050 |
Why?
| | Female | 5 | 2017 | 61564 | 0.050 |
Why?
| | Extracellular Fluid | 1 | 2020 | 32 | 0.050 |
Why?
| | Hemolysis | 1 | 2021 | 174 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2023 | 527 | 0.050 |
Why?
| | Gadolinium | 1 | 2019 | 79 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2179 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 341 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 439 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2020 | 420 | 0.040 |
Why?
| | Injections | 1 | 2018 | 167 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2017 | 89 | 0.040 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 19 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 368 | 0.040 |
Why?
| | Receptors, Purinergic | 1 | 2016 | 19 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2017 | 168 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2017 | 156 | 0.040 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 150 | 0.040 |
Why?
| | Vasoconstriction | 2 | 2007 | 213 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2484 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2017 | 379 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 870 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 2 | 2003 | 59 | 0.030 |
Why?
| | Chronic Disease | 2 | 2009 | 1636 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 688 | 0.030 |
Why?
| | Hemodynamics | 2 | 2009 | 1003 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2490 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2009 | 38 | 0.020 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 45 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 193 | 0.020 |
Why?
| | Epoprostenol | 1 | 2010 | 132 | 0.020 |
Why?
| | Cadherins | 1 | 2010 | 186 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 180 | 0.020 |
Why?
| | Endothelin B Receptor Antagonists | 1 | 2007 | 11 | 0.020 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2007 | 24 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2007 | 41 | 0.020 |
Why?
| | Adenoma | 1 | 2010 | 191 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 230 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2445 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 533 | 0.020 |
Why?
| | Perfusion | 1 | 2007 | 153 | 0.020 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2007 | 15 | 0.020 |
Why?
| | Amides | 1 | 2007 | 86 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 369 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 115 | 0.020 |
Why?
| | Nitroprusside | 1 | 2007 | 88 | 0.020 |
Why?
| | Cell Division | 1 | 2009 | 776 | 0.020 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2007 | 44 | 0.020 |
Why?
| | Cyclic GMP | 1 | 2007 | 109 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 770 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 290 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 248 | 0.020 |
Why?
| | Acetylcholine | 1 | 2007 | 208 | 0.020 |
Why?
| | Monocytes | 1 | 2009 | 513 | 0.020 |
Why?
| | Random Allocation | 1 | 2007 | 344 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 198 | 0.020 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 29 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 442 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 2007 | 260 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2005 | 394 | 0.020 |
Why?
| | beta-Arrestin 1 | 1 | 2004 | 6 | 0.020 |
Why?
| | beta-Arrestin 2 | 1 | 2004 | 4 | 0.020 |
Why?
| | beta-Arrestins | 1 | 2004 | 12 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2007 | 328 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 736 | 0.020 |
Why?
| | Clathrin | 1 | 2004 | 31 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2004 | 96 | 0.020 |
Why?
| | CHO Cells | 1 | 2004 | 143 | 0.020 |
Why?
| | Time Factors | 2 | 2008 | 6412 | 0.020 |
Why?
| | COS Cells | 1 | 2004 | 184 | 0.020 |
Why?
| | Cricetinae | 1 | 2004 | 262 | 0.020 |
Why?
| | Pyridines | 1 | 2007 | 440 | 0.020 |
Why?
| | Autonomic Denervation | 1 | 2003 | 2 | 0.010 |
Why?
| | Estradiol | 1 | 2007 | 476 | 0.010 |
Why?
| | Endocytosis | 1 | 2004 | 156 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2003 | 40 | 0.010 |
Why?
| | Testosterone | 1 | 2007 | 351 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2004 | 314 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 204 | 0.010 |
Why?
| | Immunoblotting | 1 | 2003 | 307 | 0.010 |
Why?
| | Potassium Channels | 1 | 2003 | 123 | 0.010 |
Why?
| | Protein Transport | 1 | 2004 | 412 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2004 | 395 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 823 | 0.010 |
Why?
| | Altitude | 1 | 2005 | 422 | 0.010 |
Why?
| | Models, Animal | 1 | 2003 | 363 | 0.010 |
Why?
| | Ligation | 1 | 2001 | 82 | 0.010 |
Why?
| | Calcium Signaling | 1 | 2003 | 219 | 0.010 |
Why?
| | Cell Size | 1 | 2001 | 86 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2007 | 892 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 2001 | 138 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 405 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2004 | 2071 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2275 | 0.010 |
Why?
| | Iron | 1 | 2001 | 248 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 462 | 0.010 |
Why?
| | Calcium | 1 | 2005 | 1169 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2871 | 0.010 |
Why?
| | Fibrosis | 1 | 2001 | 483 | 0.010 |
Why?
| | Aorta | 1 | 2001 | 367 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1171 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 27617 | 0.010 |
Why?
| | Gene Expression | 1 | 2002 | 1489 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 1353 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2657 | 0.010 |
Why?
| | Adult | 1 | 2017 | 31512 | 0.010 |
Why?
|
|
Karoor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|